EVOLVE II Diabetes Substudy

EVOLVE II Diabetes Substudy is a consecutive, multicentre,
single-arm, non-randomized study, with the SYNERGY stent
in medically-treated diabetic patients.

  • Patients with ≤3 native coronary artery lesions in ≤2 major
    epicardial vessels;
  • Lesion length ≤34 mm, RVD ≥2.25 mm ≤ 4.0, % DS≥50<100

SYNERGY Stent Investigator Sponsored Research Infographic SYNERGY Stent Investigator Sponsored Research Infographic